TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
active
Official procurement procedure

Compounded mAbs - Cancer Therapies

Pharmaceutical products
Pharmacy services
UK
South East (UKJ)
Official notice
Published value
£216,000,000
Submission deadline 22 Jun 2026, 12:00 BST
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Berkshire Healthcare NHS Foundation Trust: "Compounded mAbs - Cancer Therapies". Published status: active. Published value: £216,000,000. 2 published lots. Recorded submission deadline: 22 Jun 2026, 12:00 BST. See the official notice for participation instructions.
Contracting AuthorityBerkshire Healthcare NHS Foundation TrustScope & CategoriesNot publishedSubmission Window
Closed
22 Jun 2026, 12:00 BST
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£216,000,000
Bidder Intelligence · Authority Profile: Berkshire Healthcare NHS Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Berkshire Healthcare NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 9 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBerkshire Healthcare NHS Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published12 May 2026, 09:47 BST
Last source update12 May 2026, 09:47 BST
Recurring procurementYes
ClassificationPharmaceutical products, Pharmacy services
Delivery area
UK
South East (UKJ)
OCIDocds-h6vhtk-0693de
What is being bought
Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters’ Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market
What changed
From the official release history
  1. Official notice release published
    12 May 2026, 09:47 BST
  2. Submission deadline changed to 22 Jun 2026, 12:00 BST
    12 May 2026, 09:47 BST
  3. Published value updated to £216,000,000
    7 May 2026, 16:42 BST
  4. Status changed to active
    7 May 2026, 16:42 BST
  5. Official notice release published
    7 May 2026, 16:42 BST
  6. Submission deadline changed to 8 Jun 2026, 12:15 BST
    7 May 2026, 16:42 BST
  7. Buyer information updated
    7 May 2026, 16:42 BST
  8. Published tender amendment
    Not published
    Change to tender period resulting in the following alteration: Enquiry deadline change to 16/06/2026, 12.00pm Tender submission deadline change to 22/06/26, 12.00pm
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1
    active
    Published value£170,640,000
    High Volume Products - 5 molecules / all brands
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2
    active
    Published value£45,360,000
    Lower Volume Products - 13 molecules / all brands
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    12 May 2026, 09:47 BST
  2. Submission deadline
    22 Jun 2026, 12:00 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Berkshire Healthcare NHS Foundation Trust

Contracting authority GB-PPON-PVLX-5425-VJZN
View buyer profile

  • Berkshire Healthcare NHS Foundation Trust
    buyer

    GB-PPON: PVLX-5425-VJZN
    London House, London Road, Bracknell, UKJ11, RG12 2UT, GB
    neelan.moodley@berkshire.nhs.uk
Documents (3)
Official links; attachments are not copied
Related procedures (0)
No data
No related procedures published